248 related articles for article (PubMed ID: 23100493)
1. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis.
Zondag W; Kooiman J; Klok FA; Dekkers OM; Huisman MV
Eur Respir J; 2013 Jul; 42(1):134-44. PubMed ID: 23100493
[TBL] [Abstract][Full Text] [Related]
2. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.
Aujesky D; Roy PM; Verschuren F; Righini M; Osterwalder J; Egloff M; Renaud B; Verhamme P; Stone RA; Legall C; Sanchez O; Pugh NA; N'gako A; Cornuz J; Hugli O; Beer HJ; Perrier A; Fine MJ; Yealy DM
Lancet; 2011 Jul; 378(9785):41-8. PubMed ID: 21703676
[TBL] [Abstract][Full Text] [Related]
3. Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism.
Zondag W; Hiddinga BI; Crobach MJ; Labots G; Dolsma A; Durian M; Faber LM; Hofstee HM; Melissant CF; Ullmann EF; Vingerhoets LM; de Vreede MJ; Huisman MV;
Eur Respir J; 2013 Mar; 41(3):588-92. PubMed ID: 22790909
[TBL] [Abstract][Full Text] [Related]
4. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
5. Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.
Piran S; Le Gal G; Wells PS; Gandara E; Righini M; Rodger MA; Carrier M
Thromb Res; 2013 Nov; 132(5):515-9. PubMed ID: 24035045
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: findings from the RIETE Registry.
Maestre A; Sánchez R; Rosa V; Aujesky D; Lorenzo A; Barillari G; Monreal M;
Eur J Intern Med; 2010 Oct; 21(5):377-82. PubMed ID: 20816588
[TBL] [Abstract][Full Text] [Related]
7. Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism.
Roy PM; Corsi DJ; Carrier M; Theogene A; de Wit C; Dennie C; Le Gal G; Delluc A; Moumneh T; Rodger M; Wells P; Gandara E
J Thromb Haemost; 2017 Apr; 15(4):685-694. PubMed ID: 28106343
[TBL] [Abstract][Full Text] [Related]
8. Home treatment in pulmonary embolism.
Otero R; Uresandi F; Jiménez D; Cabezudo MA; Oribe M; Nauffal D; Conget F; Rodríguez C; Cayuela A
Thromb Res; 2010 Jul; 126(1):e1-5. PubMed ID: 19853892
[TBL] [Abstract][Full Text] [Related]
9. Are we ready to start outpatient treatment for pulmonary embolism?
Meyer G
Thromb Haemost; 2008 Nov; 100(5):736-7. PubMed ID: 18989512
[No Abstract] [Full Text] [Related]
10. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review.
Janjua M; Badshah A; Matta F; Danescu LG; Yaekoub AY; Stein PD
Thromb Haemost; 2008 Nov; 100(5):756-61. PubMed ID: 18989517
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
13. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
14. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
15. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review.
Squizzato A; Galli M; Dentali F; Ageno W
Eur Respir J; 2009 May; 33(5):1148-55. PubMed ID: 19407049
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
[TBL] [Abstract][Full Text] [Related]
19. [The optimal duration of anticoagulant treatment following pulmonary embolism].
Couturaud F
Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.
den Exter PL; Hooijer J; Dekkers OM; Huisman MV
J Clin Oncol; 2011 Jun; 29(17):2405-9. PubMed ID: 21555690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
